Devices › Stimulator, spinal-cord, totally implanted for pain relief
Device brand name · Scs ipg
Evoke Closed Loop Stimulator (CLS) (US): medical device reports filed with FDA
439 reports name it, 2024–2026. Manufacturer given most often on reports: Saluda Medical. Product code LGW.
- 439
- device reports naming the brand
- 0% of all MAUDE reports · about 240 a year
- 303
- reports, 12 months to August 2026
- 136 in the 12 months before
- 0%
- classified as malfunction
- 27.3% across the product code
- 0.5%
- classified as death, as reported
- 2 reports · not verified by FDA
439 medical device reports received by FDA name the brand "Evoke Closed Loop Stimulator (CLS) (US)" (scs ipg); the manufacturer given most often on reports is Saluda Medical; received from September 2024 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
303 reports arrived in the 12 months to August 2026, up 123% from 136 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.5%) and death (0.5%); across all stimulator, spinal-cord, totally implanted for pain relief reports (product code LGW) death is recorded in 0.5% and malfunction in 27.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are patient-device incompatibility (20.7%), inappropriate/inadequate shock/stimulation (14.4%) and lack of effect (9.8%). The patient problems coded most often are inadequate pain relief, implant pain and undesired nerve stimulation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 378,355 reports carrying product code LGW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Patient-device incompatibilitythe device did not suit the patient | 91 | 20.7% | 0.2% |
| Inappropriate/inadequate shock/stimulation | 63 | 14.4% | 3.7% |
| Lack of effect | 43 | 9.8% | 0% |
| Migrationthe device moved from where it was placed | 29 | 6.6% | 5.7% |
| Prophylactic removal due to corrective action | 15 | 3.4% | 0% |
| Failure to charge | 14 | 3.2% | 1.3% |
| Patient device interaction problem | 14 | 3.2% | 0.9% |
| Temperature problem | 14 | 3.2% | 1.5% |
| Charging problem | 12 | 2.7% | 11.2% |
| Connection problema connection problem | 8 | 1.8% | 1.6% |
| Delayed charge time | 8 | 1.8% | 1.8% |
| High impedance | 6 | 1.4% | 9.7% |
| Insufficient device problem information | 6 | 1.4% | 6.8% |
| Signal artifact/noise | 6 | 1.4% | 0% |
| Aborted charge | 4 | 0.9% | 0% |
| Communication or transmission problemthe device could not communicate or transmit | 4 | 0.9% | 5% |
| Failure to deliver shock/stimulation | 2 | 0.5% | 0% |
| Intermittent communication failure | 2 | 0.5% | 0% |
| Loose or intermittent connection | 2 | 0.5% | 0% |
| Low impedance | 2 | 0.5% | 0.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Inadequate pain relief | 103 | 23.5% |
| Implant pain | 87 | 19.8% |
| Undesired nerve stimulation | 34 | 7.7% |
| Impaired healingslow healing | 22 | 5% |
| Purulent discharge | 20 | 4.6% |
| Wound dehiscencea wound reopened | 20 | 4.6% |
| Discomfortdiscomfort | 14 | 3.2% |
| Painpain, site not specified | 12 | 2.7% |
| Headachehead pain | 8 | 1.8% |
| Inflammationinflammation | 8 | 1.8% |
| Limb pain | 8 | 1.8% |
| Post operative wound infection | 8 | 1.8% |
| Bacterial infectiona bacterial infection | 6 | 1.4% |
| Burning sensationa burning feeling | 6 | 1.4% |
| Cerebrospinal fluid leakage | 6 | 1.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Evoke Closed Loop Stimulator (CLS) (US) | Product code LGW | All MAUDE reports |
|---|---|---|---|
| Reports | 439 | 378,355 | 26,136,888 |
| Share of that pool | — | 0.1% | 0% |
| Classified as death, per 1,000 reports | 5 | 5 | 9 |
| Classified as injury | 99.5% | 72% | 36.2% |
| Classified as malfunction | 0% | 27.3% | 62.3% |
| Filed by the manufacturer | 50.6% | 99.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LGW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Intellis | 42,032 | 4,743 | 0% |
| Octrode Lead Kit, 60cm Length | 47,037 | 5,133 | 0.1% |
| SureScan | 33,123 | 490 | 0% |
| Precision? | 26,020 | 446 | 0.4% |
| Proclaim 5 Elite Implantable Pulse Generator | 20,816 | 2,057 | 0.1% |
| Precision Spectra ? | 16,858 | 971 | 0.5% |
| Restore Ultra | 13,500 | 39 | 0.1% |
| Eon Mini IPG, 16-Channel Rechargeable | 14,176 | 111 | 0.2% |
| Restore Sensor | 10,934 | 40 | 0.1% |
| Spectra WaveWriter? | 7,766 | 1,093 | 0.4% |
| Penta 3mm Lead, 60 cm | 9,617 | 839 | 0.3% |
| Senza | 6,423 | 718 | 15.1% |
| Eon Mini | 9,122 | 0 | 0.6% |
| Proclaim 7 Elite Implantable Pulse Generator | 5,836 | 333 | 0.1% |
| WaveWriter Alpha? | 4,965 | 1,591 | 0.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Evoke Closed Loop Stimulator (CLS) (US) reports
How many FDA reports name Evoke Closed Loop Stimulator (CLS) (US)?
439 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 303 in the latest 12 months.
What kinds of events are reported?
injury (99.5%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
patient-device incompatibility (20.7%), inappropriate/inadequate shock/stimulation (14.4%), lack of effect (9.8%), migration (6.6%) and prophylactic removal due to corrective action (3.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (50.6%) and distributor reports (49.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Evoke Closed Loop Stimulator (CLS) (US) was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.